Elucidating the Role of Tolerogenic Dendritic Cells in Immune Tolerance and Disease Progression in Multiple Myeloma
Introduction: Previous research has demonstrated that programmed death-ligand 1 (PD-L1) in multiple myeloma (MM) cells not only suppresses anti-tumor immune responses but also enhances malignant potential through the PD-L1-PD-1 interaction [Ishibashi M, et al. Cancer Immunol Res. 2016]. However, it...
Saved in:
Published in | Blood Vol. 142; no. Supplement 1; p. 6596 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English Japanese |
Published |
Elsevier Inc
02.11.2023
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!